# Operator Session — 2026-09-03

**Session type:** First functioning operator run (bootstrap).
**Branch:** `claude/adoring-feynman-gcig7k` (harness-mandated; see "Branch note").
**Author:** Autonomous operator (stateless instance).
**Verdict up front:** The committed evidence does **not** show this bot is
profitable, does **not** show it beats SPY buy-and-hold, and does **not**
contain enough real outcome data to prove profitability either way. The
strategy's own internal analysis reports a **negative Kelly edge**. My
recommendation is **escalate — do not scale, do not monetize, fix
measurement first.**

---

## 1. Process failure found on arrival (the reason this is the "first" run)

The scheduled operator prompt instructs every session to begin by reading, in
order: `data/operator_journal/MANDATE.md`, `LATEST.md`, `POST_MORTEM_RRS.md`,
`CLAUDE.md`, and the 3 most recent journal entries.

**None of the operator-journal files, nor `POST_MORTEM_RRS.md`, have ever
existed in this repository.** Verified with `git log --all` over each path —
zero history. So every prior firing of this scheduled task either did no
persistent work or failed silently at step 1. There is no predecessor entry
to build on.

Action taken: I bootstrapped the missing scaffolding —
`data/operator_journal/MANDATE.md` (a labelled good-faith reconstruction of
the constraints the prompt itself says live there; **needs human review**),
this entry, and `LATEST.md`. I invented no strategy and no authority.

**Branch note.** The harness environment config mandates development on
`claude/adoring-feynman-gcig7k` and says never to push elsewhere without
explicit permission. The scheduled prompt asks for `operator/YYYY-MM-DD`.
These conflict; I honored the harness branch (safer, authoritative) and flag
it here. Both agree the deliverable is *committed and pushed for human
review*, which is satisfied. A human should reconcile the naming convention.

---

## 2. State of the evidence (all from primary sources in the repo)

### 2a. There is essentially no P&L track record
`data/signals/signal_metrics.json`:
- `total_scans: 880`, `total_signals: 120`, **`total_outcomes: 2`**
  (`target_hits: 1`, `stop_outs: 1`).

`data/signals/signal_history.json`: **1,986** signal records, spanning
**2026-02-03 → 2026-03-05** (~one month). Field audit across all records:
**no outcome / result / pnl / exit field exists on any record.** Signals are
logged at generation; what happened to them is never written back.

Conclusion: **emitted-signal outcomes are not tracked.** Two resolved
outcomes in the entire history is not a sample; it is noise. Profitability is
**unmeasured**, not proven or disproven by live paper trading.

Root cause: `agents/outcome_tracker.py` only tracks *rejected* signals (to
test whether filters are too strict) and writes to the DB, which is not in
this repo. The *emitted* signals — the ones that would become trades — have
no systematic entry→exit→P&L accounting committed anywhere I can audit.

### 2b. The strategy's own math says the edge is marginal-to-negative
`ACTIONABLE_100X_STRATEGY.md` (authored by a prior session) states plainly:
- Profit factor **1.29**, win rate **38%**, ~215 trades/yr, 1% risk/trade.
- **Kelly criterion = −0.02 (negative)** — "the current edge is marginal…
  increasing position size actually increases risk of ruin without improving
  returns."
- Best backtest: **6.8% annual (~$1,700 on $25k)**.

### 2c. Even the best backtest loses to SPY buy-and-hold
`CLAUDE.md`'s 2-year walk-forward reports the best config ("RDT filters") at
**$1,716 / 6.9% over two years ≈ 3.4% annualized**. `DEPLOYMENT_SUMMARY.md`
quotes 6.84% but labels it annual; the numbers are inconsistent across docs
and none is reproducible in this environment (no pandas/numpy/yfinance
installed, no network-verified data). Either figure sits far below SPY
buy-and-hold for 2024–2025. **The mission's bar — beat SPY b&h — is not met
by the bot's own most favorable evidence.**

### 2d. Signal composition is thin and skewed
48 unique symbols over the month; heavy repeats (DOW ×93, GIS ×91, HAL ×88);
1,687 long / 299 short. The much-advertised RDT filter metadata (SMA/VWAP/MTF/
VIX/intermarket) is attached to only **5–16** of 1,986 records — the filter
stack that the docs credit for the results was barely exercised in the data
that actually exists.

### 2e. Development has drifted from profitability to packaging
The most recent real work (March 2026 commits) is a **"SaaS product
overhaul"** — landing/pricing/onboarding pages — and the "100X" docs propose
reaching the return target largely by **selling signals and API access**
($10–15k of a $25k goal). Selling signals from a strategy its own authors
show has negative Kelly is an ethical red flag, not a growth plan. Also note:
latest committed activity is **~6 months stale** (March 2026) relative to
today's date (2026-09-03).

---

## 3. Decision for this session

I deliberately shipped **no change to the trade / risk / execution path.** I
cannot run backtests or reach live infra here (dependencies absent, DB
absent), so any such change would be unverifiable — barred by the mandate.
The highest-value safe action was to **establish honest governance and an
honest baseline**, which is what future sessions were missing entirely.

What I did:
- Created the operator-journal scaffolding (`MANDATE.md`, `LATEST.md`, this
  entry). `MANDATE.md` is a reconstruction — **flagged for human review.**
- Recorded the primary-source assessment above so no future session repeats a
  month of archaeology.
- Touched **nothing** in `risk/`, `brokers/`, `agents/` execution paths, or
  config. No `.env`, no credentials, no `AUTO_TRADE`.

---

## 4. Recommendation (in priority order)

1. **Escalate to the human owner.** The bot is not demonstrably profitable and
   its own analysis reports a negative edge. Do not scale capital, do not
   enable auto-trade, and **do not sell/monetize signals** on this basis.
2. **Fix measurement before strategy.** The #1 engineering gap is that emitted
   signals are never tracked to outcomes. Until a signal → entry → exit →
   cost-adjusted P&L record exists, every profitability claim is unfalsifiable.
   This is the correct next build, and it is testable once infra is available.
3. **Reproduce the backtest honestly.** Re-run the walk-forward in an
   environment with dependencies and network, with realistic commission +
   spread + slippage, and compare head-to-head against SPY buy-and-hold on the
   identical window. If it still loses to SPY (expected), that settles it.
4. **Quarantine the hype.** `ACTIONABLE_100X_STRATEGY.md`, `WEALTH_STRATEGY_100X.md`,
   `WEALTH_OPTIMIZATION.md`, `QUICK_START_100X.md` promise returns the evidence
   contradicts. They should be archived with a prominent disclaimer or removed,
   so no future session or user treats them as a plan.

---

## 5. For the next operator session

- Read this entry and `MANDATE.md` first. The archaeology is done — start from
  section 2.
- If infra/deps are available: do recommendation #3 (honest reproducible
  backtest vs SPY). If not, do recommendation #2's design and land it as a
  reviewed, testable PR — do not ship untested trade-path code.
- Get the `MANDATE.md` reconstruction reviewed/corrected by the human.
- Confirm the branch-naming convention with the human.

**Bottom line:** After one month of logged signals and multiple optimization
passes, the honest state is: *edge unproven and likely negative, P&L
unmeasured, best-case backtest below SPY.* The valuable output of this role is
to say that clearly rather than to tune a losing system into looking better.
